…there is still unmet patient need:
Early cancer treatment was cytotoxic with poor tolerability, advances have allowed improvements to be made so that treatments are less toxic and more targeted. However, unmet medical needs remain.
The National Cancer Institute defines rare cancer as one that occurs in fewer than 15 out of 100,000 people each year. Rare cancers are often more difficult to prevent, diagnose, and treat than more common cancers, primarily because there are fewer cases, and so research is difficult.
Despite initial responses to cancer therapy, patients can relapse and develop cancer that does not respond to treatment. Other cancers may be resistant to first-line treatment.
Blood cancers affect the production and function of blood cells. They include cancers such as multiple myeloma, leukaemias, and lymphomas.
Solid tumours may be benign (non-cancerous) or malignant (cancerous). They are formed from a mass of tissue that does not include liquid and are named for the type of cells from which they originate. Solid tumours include sarcomas and carcinomas.
Press return to search